Medinex Past Earnings Performance
Past criteria checks 1/6
Medinex's earnings have been declining at an average annual rate of -6.4%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 3.2% per year. Medinex's return on equity is 5.4%, and it has net margins of 8.2%.
Key information
-6.4%
Earnings growth rate
-7.5%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 3.2% |
| Return on equity | 5.4% |
| Net Margin | 8.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Medinex makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 13 | 1 | 0 | 0 |
| 31 Dec 23 | 12 | 1 | 0 | 0 |
| 30 Sep 23 | 12 | 2 | 0 | 0 |
| 30 Jun 23 | 12 | 2 | 0 | 0 |
| 31 Mar 23 | 13 | 2 | 0 | 0 |
| 31 Dec 22 | 13 | 2 | 0 | 0 |
| 30 Sep 22 | 14 | 1 | 0 | 0 |
| 30 Jun 22 | 13 | 2 | 0 | 0 |
| 31 Mar 22 | 12 | 3 | 0 | 0 |
| 31 Dec 21 | 12 | 3 | 0 | 0 |
| 30 Sep 21 | 12 | 4 | 0 | 0 |
| 30 Jun 21 | 11 | 4 | 0 | 0 |
| 31 Mar 21 | 11 | 3 | 0 | 0 |
| 30 Sep 20 | 11 | 3 | 0 | 0 |
| 30 Jun 20 | 12 | 3 | 0 | 0 |
| 31 Mar 20 | 13 | 3 | 0 | 0 |
| 30 Jun 19 | 11 | 1 | 0 | 0 |
| 31 Mar 19 | 10 | 1 | 0 | 0 |
| 31 Dec 18 | 9 | 1 | 0 | 0 |
| 30 Sep 18 | 8 | 1 | 0 | 0 |
| 30 Jun 18 | 6 | 1 | 0 | 0 |
| 31 Mar 18 | 5 | 1 | 0 | 0 |
| 31 Dec 17 | 3 | 1 | 0 | 0 |
| 31 Dec 16 | 2 | 1 | 0 | 0 |
| 31 Dec 15 | 1 | 0 | 0 | 0 |
Quality Earnings: OTX has high quality earnings.
Growing Profit Margin: OTX's current net profit margins (8.2%) are lower than last year (13.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OTX's earnings have declined by 6.4% per year over the past 5 years.
Accelerating Growth: OTX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: OTX had negative earnings growth (-39.2%) over the past year, making it difficult to compare to the Healthcare industry average (-35.5%).
Return on Equity
High ROE: OTX's Return on Equity (5.4%) is considered low.